FusionPharm completes first sale and financing in Massachusetts Cannabis Market

        Print
| Source: FusionPharm, Inc.

Denver, Colorado, Feb. 11, 2014 (GLOBE NEWSWIRE) -- FusionPharm, Inc. (OTC: FSPM), manufacturer of the PharmPod™ (www.pharmpods.com )professional cultivation system is proud to welcome The Greeneway Wellness Foundation to its growing family of professional cannabis cultivators.  

The Greeneway received 3 of the 35 available licenses in Massachusetts.

Total anticipated order size will be in excess of $4million and FusionPharm will finance 50% of the project costs over a two-year period.

"The team at The Greeneway is exceptional and will provide outstanding patient care and service to the Massachusetts market for years to come" stated FusionPharm CEO Scott Dittman "we are excited to be a part of the team."

"We are confident that we will have the most modern and efficient cultivation center in existence when we are done, " commented Greeneway CEO John Greene "and we couldn't have done it without the help of PharmPods". 

"From initial conceptual design of our facility to layout and process flow the PharmPods team was there every step of the way," continued Mr. Greene "and providing $2million in financing allows us to spread a significant portion of our capital outlay over the timeframe when we are making money, rather than having to absorb all of those costs up front." 

"We have been providing financing to our state licensed growers since 2011" noted Mr. Dittman "and will continue to do so for all of our new licensed customers".

PharmPod™ units are currently manufactured by FusionPharm in Colorado.  Additional manufacturing facilities are planned for the east and west coast of the United States in 2014.

About FusionPharm Inc. (FSPM)

FusionPharm, Inc. (FSPM) (www.fusionpharminc.com) was organized to capitalize on opportunities present in the rapidly growing vertical farming and cannabis industries. FusionPharm's primary focus is the development and deployment of the patent pending PharmPods™ advanced hydroponic commercial cultivation systems. PharmPods are constructed from standard ISO steel shipping containers that are repurposed for use in indoor controlled environment agriculture. Modular, stackable, cost competitive and financeable, PharmPods have become the industry leader for professional, commercial scale indoor plant cultivation

Cautionary Language Concerning Forward-Looking Statements

This release contains "forward-looking statements" that include information relating to future events and future financial and operating performance.  The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved.  Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for GrowLife's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in GrowLife's filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include statements regarding future sales, costs and market acceptance of products as well as regulatory actions at the State or Federal level.  For a more detailed description of the risk factors and uncertainties affecting GrowLife, Inc. please refer to the Company's Securities and Exchange Commission filings, which are available at www.sec.gov.  GrowLife, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

FusionPharm Inc.

(720) 458-0686